InMed Pharmaceuticals Inc. (INM)
NASDAQ·Healthcare·Biotechnology
$1.52
-3.80%
Mkt Cap $1.54M
No analyst coverage available
We don't have analyst ratings or price target data for InMed Pharmaceuticals Inc. yet. Coverage gaps are common for sub-$1B market caps and recently-listed names.